Literature DB >> 29758404

Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator.

Dominic A M J Theuns1, Tom F Brouwer2, Paul W Jones3, Venugopal Allavatam3, Steven Donnelley3, Angelo Auricchio4, Reinoud E Knops2, Martin C Burke5.   

Abstract

BACKGROUND: Most inappropriate shocks from the subcutaneous implantable cardioverter-defibrillator (S-ICD) are caused by cardiac oversensing. A novel sensing methodology, SMART Pass (SP; Boston Scientific Corporation, Natick, MA), aims to reduce cardiac oversensing.
OBJECTIVE: The purpose of this study was to evaluate the effect of SP on shocks in ambulatory patients with S-ICD.
METHODS: Patients implanted in 2015-2016 and enrolled in a remote patient monitoring system were included and followed for 1 year. Shocks were adjudicated by 3 independent blinded reviewers as appropriate or inappropriate. Shock incidence was calculated for patients with SP programmed enabled or disabled at implantation, censoring patients when SP programming changed or at the last transmission. The SP setting (enabled vs disabled) was modeled as a time-dependent Cox regression variable.
RESULTS: The cohort consisted of 1984 patients, and a total of 880 shocks were adjudicated. At implantation, SP was enabled in 655 patients (33%) and disabled in 1329 patients (67%). SP reduced the risk for the first inappropriate shock by 50% (P < .001) and the risk for all inappropriate shocks by 68% (P < .001) in multivariate analysis adjusted for age and device programming. The incidence of inappropriate shocks was 4.3% in the SP enabled arm vs 9.7% in the SP disabled arm. The incidence of appropriate shocks was similar (5.2% vs 6.6%; P = .18) along with the time to treat the first appropriate shock (17.4 seconds vs 16.7 seconds; P = .92) for SP enabled vs disabled, respectively.
CONCLUSION: This prospective blinded evaluation of the SP filter demonstrates that enabling the SP filter results in a significant reduction of inappropriate shocks by the S-ICD without a negative effect on appropriate shocks.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Appropriate shocks; Arrhythmias; Inappropriate shocks; Oversensing; Subcutaneous ICD

Mesh:

Year:  2018        PMID: 29758404     DOI: 10.1016/j.hrthm.2018.05.011

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  16 in total

Review 1.  Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies.

Authors:  Khi Yung Fong; Colin Jun Rong Ng; Yue Wang; Colin Yeo; Vern Hsen Tan
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

2.  Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.

Authors:  Babak Nazer; Zack Dale; Gianmarco Carrassa; Nosheen Reza; Tuna Ustunkaya; Nikolaos Papoutsidakis; Andrew Gray; Stacey J Howell; Miriam R Elman; Paolo Pieragnoli; Giuseppe Ricciardi; Daniel Jacoby; David S Frankel; Anjali Owens; Iacopo Olivotto; Stephen B Heitner
Journal:  Heart Rhythm       Date:  2020-02-18       Impact factor: 6.343

3.  Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study.

Authors:  Pier D Lambiase; Dominic A Theuns; Francis Murgatroyd; Craig Barr; Lars Eckardt; Petr Neuzil; Marcoen Scholten; Margaret Hood; Jȕrgen Kuschyk; Amy J Brisben; Nathan Carter; Timothy M Stivland; Reinoud Knops; Lucas V A Boersma
Journal:  Eur Heart J       Date:  2022-06-01       Impact factor: 35.855

4.  A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator.

Authors:  Kentaro Goto; Yuichi Ono; Yuki Osaka; Ken Kurihara; Kenichiro Otomo; Tetsuo Sasano
Journal:  HeartRhythm Case Rep       Date:  2020-03-08

5.  Quantification of Electromechanical Coupling to Prevent Inappropriate Implantable Cardioverter-Defibrillator Shocks.

Authors:  Daniel Keene; Matthew J Shun-Shin; Ahran D Arnold; James P Howard; David Lefroy; D Wyn Davies; Phang Boon Lim; Fu Siong Ng; Michael Koa-Wing; Norman A Qureshi; Nick W F Linton; Jaymin S Shah; Nicholas S Peters; Prapa Kanagaratnam; Darrel P Francis; Zachary I Whinnett
Journal:  JACC Clin Electrophysiol       Date:  2019-03-27

6.  Early inappropriate shock in a subcutaneous cardiac defibrillator due to subcutaneous air.

Authors:  Ryo Nishinarita; Jun Kishihara; Gen Matsuura; Yuki Arakawa; Shuhei Kobayashi; Yuki Shirakawa; Ai Horiguchi; Hironori Nakamura; Naruya Ishizue; Jun Oikawa; Hidehira Fukaya; Shinichi Niwano; Junya Ako
Journal:  J Arrhythm       Date:  2019-06-17

7.  A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter-defibrillator.

Authors:  Yuji Ishida; Shingo Sasaki; Yuichi Toyama; Kimitaka Nishizaki; Yoshihiro Shoji; Takahiko Kinjo; Taihei Itoh; Daisuke Horiuchi; Masaomi Kimura; Michael R Gold; Hirofumi Tomita
Journal:  Heart Rhythm O2       Date:  2020-04-27

8.  Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes.

Authors:  Pier D Lambiase; Lars Eckardt; Dominic A Theuns; Timothy R Betts; Andreas L Kyriacou; Elizabeth Duffy; Reinoud Knops
Journal:  Heart Rhythm O2       Date:  2020-10-28

9.  Sudden depression of R-wave amplitude in a patient who underwent subcutaneous implantable cardioverter-defibrillator implantation.

Authors:  Masaki Takahashi; Hidekazu Kondo; Tetsuji Shinohara; Naohiko Takahashi
Journal:  HeartRhythm Case Rep       Date:  2021-04-15

10.  RV lead placement - A forgotten cause of right heart failure.

Authors:  Muhammad Arslan Cheema; Talal Almas; Waqas Ullah; Donald Haas
Journal:  Ann Med Surg (Lond)       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.